Coste-efectividad de la polipíldora CNIC frente a los monocomponentes separados en prevención secundaria cardiovascular en España
Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment
Impacto económico del uso de patiromer en enfermedad renal crónica o insuficiencia cardíaca para el tratamiento de la hiperpotasemia crónica en España
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study
Anemia asociada a la enfermedad renal crónica: Impacto asistencial y económico en España
Hiperpotasemia crónica: Impacto asistencial y económico en España
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
